Regulation of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 cells by 2"-hydroxy-3"-en-anhydroicaritin involves down-regulation of NF-κB and MAPK expression

International Immunopharmacology

Volumn 10, Issue 9, 2010, Pages 995-1002

  Ci, Xinxin ^a   Liang, Xiaoying ^a   Luo, Guojun ^b   Yu, Qinlei ^c   Li, Hongyu ^a   Wang, Dacheng ^a   Li, Rongtao ^b   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

^b KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c General Situation of Jilin Provincial Center for Animal Disease Control and Prevention   (China)

Author keywords

2" hydroxy 3" en anhydroicaritin; COX 2; INOS; MAPKs; NF B

Indexed keywords

2'' HYDROXY 3'' EN ANHYDROICARITIN; BETA ACTIN; CYCLOOXYGENASE 2; FLAVONE DERIVATIVE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROSTAGLANDIN E2; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL NUCLEUS; CHINESE HERB; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; EPIMEDIUM BREVICORNUM; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; DOWN-REGULATION; FLAVONOLS; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION;

EID: 77955924890     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.04.015     Document Type: Article

References (40)

1. Minagar A., Shapshak P., Fujimura R., Ownby R., Heyes M., Eisdorfer C. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 2002, 202:13-23.
2. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001, 13:85-94.
3. Aderem A. Role of Toll-like receptors in inflammatory response in macrophages Crit. Care Med 2001, 29:16-18.
4. Ritchlin C.T., Haas-Smith S.A., Li P., Hicks D.G., Schwarz E.M. Mechanisms of TNF-alpha and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003, 111:821-831.
5. Ci X.X., Song Y., Zeng F.Q., Zhang X.M., Li H.Y., Wang X.R., et al. Ceftiofur impairs pro-inflammatory cytokine secretion through the inhibition of the activation of NF-κB and MAPK. Biochem Biophys Res Commun 2008, 372:73-77.
6. Zhang X.M., Song Y., Ci X.X., An N., Fan J.W., Cui J.Q., et al. Effects of florfenicol on early cytokine responses and survival in murine endotoxemia. Int Immunopharmacol 2008, 8:982-988.
7. Zhang X.M., Li H.Y., Feng H.H., Xiong H.Z., Zhang L., Song Y., et al. Valnemulin downregulates nitric oxide, prostaglandin E2, and cytokine production via inhibition of NF-κB and MAPK activity. Int Immunopharmacol 2009, 9:810-816.
8. Hoffmann A., Levchenko A., Scott M.L., Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 2002, 8:1241-1245.
9. Sanchez-Perez I., Benitah S.A., Martinez-Gomaroz M., Lacal J.C., Perona R. Cell stress and MEKK1-mediated c-Jun activation modulate NF-kappaB activity and cell viability. Mol Biol Cell 2002, 13:2933-2945.
10. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., et al. Molecular mechanism underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 2001, 480-481.
11. Lappas M., Permezel M., Georgiou H.M., Rice G.E. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod 2002, 67:668-673.
12. Zhao Q., Shepherd E.G., Manson M.E., Nelin L.D., Sorokin A., Liu Y. The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J Biol Chem 2005, 280:8101-8105.
13. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu Rev Immunol 2003, 21:335-376.
14. Chi Y.S., Lim H., Park H., Kim H.P. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem Pharmacol 2003, 66:1271-1278.
15. Barak V., Kalickman I., Halperin T., Birkenfeld S., Ginsburq I. PADMA-28, a Tibetan herbal preparation is an inhibitor of inflammatory cytokine production. Eur Cytokine Netw 2004, 15:203-209.
16. Genovese M.C. Biologic therapies in clinical development for the treatment of rheumatoid arthritis. J Clin Rheumatol 2005, 11:S45-S50.
17. Perez-vizcaino F., Duarte J., Jimenez R., Santos-Buelga C., Osuna A. Anti-hypertensive effects of the flavonoid quercetin. Pharmacol Rep 2009, 61:67-75.
18. Choi H.J., Kim J.H., Lee C.H., Ahn Y.J., Song J.H., Baek S.H., et al. Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antivir Res 2009, 81:77-81.
19. Galluzzo P., Martini C., Bulzomi P., Leone S., Bolli A., Pallottini V., et al. Quercetin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor alpha-dependent mechanisms. Mol Nutr Food Res 2009, 53(6):699-708.
20. Bontempo P., Mita L., Miceli M., Doto A., Nebbioso A., De Bellis F., et al. Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities. Int J Biochem Cell Biol 2007, 39:1902-1914.
21. Manthey J.A., Bendele P. Anti-inflammatory activity of an orange peel polymethoxylated flavone, 3', 4', 3, 5, 6, 7, 8-heptamethoxyflavone, in the rat carrageenan/paw edema and mouse lipopolysaccharide-challenge assays. J Agric Food Chem 2008, 56(20):9399-9403.
22. Shin E.K., Kwon H.S., Kim Y.H., Shin H.K., Kim J.K. A natural flavone, improves murine inflammatory bowel diseases. Biochem Biophys Res Commun 2009, 381:502-507.
23. Lin N., Sato T., Takayama Y., Mimaki Y., Sashida Y., Yano M., et al. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem Pharmacol 2003, 15:2065-2071.
24. Yap S.P., Shen P., Butler M.S., Gong Y., Loy C.J., Yong E.L. New estrogenic prenylflavone from Epimedium brevicornum inhibits the growth of breast cancer cells. Planta Med 2005, 71:114-119.
25. Pan Y., Zhang W.Y., Xia X., Kong L.D. Effects of icariin on hypothalamic-pituitary-adrenal axis and cytokine levels in stressed Sprague-Dawley rats. Biol Pharm Bull 2006, 29:2399-2403.
26. Wu B., Yan S., Lin Z., Wang Q., Yang Y., Yang G., et al. Metabonomic study on ageing: NMR-based investigation into rat urinary metabolites and the effect of the total flavone of Epimedium. Mol Biosyst 2008, 4:855-861.
27. Cai W.J., Zhang X.M., Huang J.H. Effects of epimedium flavonoids in retarding aging of C. elegans. Zhongguo Zhong Xi Yi Jie He Za Zhi 2008, 28:522-525.
28. Meng F.H., Li Y.B., Xiong Z.L., Jiang Z.M., Li F.M. Osteoblastic proliferative activity of Epimedium brevicornum Maxim. Phytomedicine 2005, 12:189-193.
29. Chung B.H., Kim J.D., Kim C.K., Kim J.H., Won M.H., Lee H.S., et al. Icariin stimulates angiogenenesis by activating the MEK/ERK- and P13K/AKt/eNOS-dependent signal pathways in human endothelial cells. Biochem Biophys Res Commun 2008, 376:404-408.
30. Zhang Y.F., Yu Q.H. The anti-inflammatory effects of total flavonoids of Epimedium. J Shengyang Pharm Univ 1999, 16:122-124.
31. Luo G.J., Ci X.X., Ren R., Wu Z.Y., Li H.M., Li H.Z., et al. Isolation of two new prenylflavonols from Epimedium brevicornum and their effects on cytokine production in vitro. Planta Med 2009, 75:1-5.
32. Mizuno M., Iinuma M., Tanaka T. Flavonol glycosides in the roots of Epimedium diphyllum. Phytochemistry 1988, 27:3645-3648.
33. Ding P.L., Chen D.F., Bastow K.F., Nyarko A.K., Wang X.H., Lee K.H. Cytotoxic isoprenylated flavonoids from the roots of Sophora flavescens. HCA 2004, 87:2574-2580.
34. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 1992, 24:145-149.
35. Baeuerle P.A., Baltimore D. NF-kappa B: ten years after. Cell 1996, 87:13-20.
36. Paul A., Wilson S., Belham C.M., Robinson C.J., Scott P.H., Gould G.W., et al. Stress-activated protein kinases: activation, regulation and function. Cell Signal 1997, 9:403-410.
37. Saccani S., Marazzi I., Beg A.A., Natoli G. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response. J Exp Med 2004, 200:107-113.
38. Rao K.M. MAP kinase activation in macrophages. J Leukoc Biol 2001, 69:3-10.
39. Jiang J.X., Zhang Y., Ji S.H., Zhu P., Wang Z.G. Kinetics of mitogen-activated protein kinase family in lipopolysaccharidestimulated mouse Kupffer cells and their role in cytokine production. Shock 2002, 18:336-341.
40. Xaragori A., Roussos C., Papapetropoulos A. Inhibition of LPS stimulated pathways in macrophages by the flavonoid luteolin. Br J Pharmacol 2002, 136:1058-1064.